COMPARISON OF DEXMEDETOMIDINE VERSUS MAGNESIUM SULPHATE IN LAPAROSCOPIC CHOLECYSTECTOMY - A BIS AND ANI GUIDED STUDY

Main Article Content

Dr. Komal Paswan
Dr. Badri Prasad Das
Dr. Anup Kumar Harichandan
Dr. Sudhansu Sekhar Nayak
Dr. Gyanendra Kumar Sinha

Keywords

Laparoscopic Cholecystectomy, TIVA, Dexmedetomidine, Magnesium Sulfate, BIS, ANI

Abstract

BACKGROUND: Laparoscopic cholecystectomy is a routinely performed surgery always demanding a stable intraoperative hemodyanamic status. The pneumoperitonium and the patient positions required for laparoscopy induce pathophysiologic changes that complicate anaesthetic management. And search for an ideal anaesthetic adjuvant for attenuating such changes is still on. The present study was conducted to compare the effects of dexmedetomidine and magnesium sulfate as adjuvant in maintaining perioperative cardiovascular stability, with propofol consumption as a part of total intravenous anaesthesia (TIVA) and postoperative analgesia in laparoscopic cholecystectomy, with Bispectral index (BIS), and Analgesia and Nociception Index (ANI) as a guidance.


MATERIAL AND METHODS: After thorough pre-anaesthetic check-up, 60 adult patients aged 20-60yrs with ASA physical status of I and II, belonging to either sex and scheduled for undergoing laparoscopic cholecystectomy, were randomly allocated into two groups of 30 each, using computer generated random table, to receive blinded study drugs:


Group 1: received magnesium sulfate 30mg/kg bolus (made to 20ml saline) infused over 20min, 20min before induction, followed by 15mg/kg/hr.


Group 2: received dexmedetomidine at a bolus dose of 1 mcg/kg (made to 20ml saline) infused over 20min, 20 min before induction, followed by 0.5 mcg/kg/hr.


This study was carried over a period of 15 month.


Statistical analysis was done using SPSS version 20.0. Sample size was calculated using previous similar studies, and keeping α <5 % and β= 20%, power of study=80%. Mean ± SD and Student's t-test was used for statistical analysis and comparison of age, weight, haemodynamic parameters, dose of study drugs used, dose of propofol, time to extubation, and the use of rescue analgesia between the two groups, with a p-value of <0.05 considered significant.


RESULTS: In our study we found that the mean requirement of propofol in group 1 at the time of induction in mg was 57.00±9.52 and in group 2 it was 58.33±9.85 with no significant difference (p=0.596). With maintenance infusion of magnesium and dexmedetomidine in the recommended mean dose (15mg/kg/hr and 0.5mcg/kg/hr respectively), the mean requirement of propofol infusion for maintenance of depth of anaesthesia (to maintain BIS and ANI 40-60) was 133.33±41.91 mg (in group 1) and 183.33+51.107 mg (in group 2) with a statistical significant difference (p= 0.03). Thus, there was a significant propofol sparing effect of around 56 mg, with magnesium use. With 1 ampule of magnesium sulfate being Rs 8.50 and 1 ampule of dexmedetomidine being Rs. 759, the mean cost was 152.4+22.2 and 909.4+22.2 respectively. Hence we got a significant cost effectiveness for patients with magnesium use. Therefore as per this study the sedative property is almost equal in both drugs and less propofol required to maintain adequate depth of anaesthesia in magnesium sulfate.


CONCLUSION: Hence, this study concludes that magnesium sulfate shows a promising role as an adjunct to total intravenous anesthesia (TIVA) for patients undergoing laparoscopic cholecystectomy. It offers comparable intraoperative hemodynamics, a higher propofol-sparing effect for maintaining general anesthesia, better postoperative analgesia, with cost-effectiveness, as compared to dexmedetomidine.

Abstract 71 | PDF Downloads 5

References

[1] Sahoo S, Das BP, Mohanty P, Nayak SS. Comparison of Laparoscopic Transversus Abdominis Plane Block versus Conventional Port Site Infiltration for Postoperative Analgesia after Laparoscopic Cholecystectomy. International Journal of Medical Science and Current Research. 3(4);2020:420-7.
[2] Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anaesth Analg 1997;85(5):113642.
[3] Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P. The haemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anaesth Analg 2000;90(4):834-39.
[4] Talke P, Lobo E, Brown R. Systemically administered alpha 2- agonist – induced peripheral vasoconstriction in humans. Anaesthesiology 2003;99(1):65-70.
[5] Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984;309(5965):261-3.
[6] Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108(1):188-93.
[7] Lee DH, Kwon IC. Magnesium sulfate has beneficial effects as an adjuvant during general anaesthesia for Caesarean section. Br J Anaesth 2009;103(6):861-6.
[8] Jee D, Lee D, Yun S, Lee C. Magnesium sulfate attenuates arterial pressure increase during laparoscopic cholecystectomy. Br J Anaesth 2009;103(4):484-9.
[9] Jaakola ML, Ali-Melkkilä T, Kanto J, Kallio A, Scheinin H, Scheinin M. Dexemeditomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Br j Anaesth 1992;68(6):570-5.
[10] Lawrence CJ, De Lange S. Effects of a single pre- operative dexmedetomidine dose on isoflurane requirement and perioperative haemodynamic stability. Anaesthesia 1997;52(8):736-44.
[11] Ghodki PS, Thombre SK, Sardesai SP, Harnagle KD. Dexmedetomidine as an anaesthetic adjuvant in laparoscopic surgery; an observational study using entropy monitoring. J Anaesthesiology Clin pharmacol 2012;28(3):334-8.
[12] Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anaesthesiology 1992;76(6):948-52.
[13] Choi JC, Yoon KB, Um DJ, Kim C, Kim JS, Lee SG. Intravenous magnesium sulfate administration reduces propofol infusion requirements during maintenance of propofol-N2O anaesthesia. Anaesthesiology 2002;97(5):1137-41.
[14] Seyhan TO, Tugrul M, Sungur MO, Kayacan S, Telci L, Pembeci K, et al. Effects of three different dose regimens of magnesium on propofol requirements, haemodynamic variables and postoperative pain relief in gynecocological surgery. Br J Anaesth 2006;96(2):247-52.
[15] Walia C, Gupta R, Kaur M, Mahajan L, Kaur G, Kaur B. propofol sparing effect of dexmedetomidine and magnesium sulfate during BIS targeted anaesthesia: a prospective, randomized, placebo controlled trial. Journal of Anaesthesiology Clinical Pharmacology 2018;34(3) 335-40.
[16] Ali RM, Rabie AH, Elshalakany NA, El Gindy TM. Effect of intraperitoneal magnesium sulfate on haemodynamic changes and its analgesic and antiemetic effect in laparoscopic cholecystectomy. Ains shams. J Anaesthesiology 2015;8(2) 153-9.